Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |